Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
139.83
Dollar change
-1.15
Percentage change
-0.82
%
IndexNDX, S&P 500 P/E- EPS (ttm)-7.34 Insider Own0.45% Shs Outstand159.00M Perf Week3.16%
Market Cap22.22B Forward P/E56.88 EPS next Y2.46 Insider Trans0.99% Shs Float158.19M Perf Month-5.01%
Income-1161.00M PEG- EPS next Q0.05 Inst Own91.07% Short Float3.03% Perf Quarter44.84%
Sales4.50B P/S4.93 EPS this Y5.44% Inst Trans2.73% Short Ratio2.26 Perf Half Y-13.65%
Book/sh36.13 P/B3.87 EPS next Y171.09% ROA-10.38% Short Interest4.79M Perf Year-29.80%
Cash/sh6.63 P/C21.08 EPS next 5Y22.90% ROE-18.81% 52W Range89.00 - 238.55 Perf YTD0.42%
Dividend Est.- P/FCF78.79 EPS past 5Y- ROI-14.66% 52W High-41.38% Beta1.19
Dividend TTM- Quick Ratio1.29 Sales past 5Y7.40% Gross Margin60.97% 52W Low57.11% ATR (14)5.55
Dividend Ex-Date- Current Ratio1.66 EPS Y/Y TTM73.83% Oper. Margin-1.62% RSI (14)51.10 Volatility3.66% 3.85%
Employees12010 Debt/Eq0.39 Sales Y/Y TTM-1.72% Profit Margin-25.78% Recom2.38 Target Price153.13
Option/ShortYes / Yes LT Debt/Eq0.38 EPS Q/Q-24.92% Payout- Rel Volume0.57 Prev Close140.98
Sales Surprise3.19% EPS Surprise652.69% Sales Q/Q3.60% EarningsFeb 08 AMC Avg Volume2.12M Price139.83
SMA20-0.51% SMA500.63% SMA200-8.36% Trades Volume1,226,294 Change-0.82%
Date Action Analyst Rating Change Price Target Change
Jan-16-24Downgrade HSBC Securities Buy → Hold
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $144
Dec-18-23Upgrade Scotiabank Sector Perform → Sector Outperform $185
Dec-15-23Upgrade Bernstein Underperform → Mkt Perform
Dec-14-23Initiated Stephens Overweight $170
Dec-14-23Initiated Guggenheim Buy $155
Dec-13-23Initiated Wolfe Research Outperform $175
Dec-12-23Downgrade BofA Securities Neutral → Underperform $140 → $100
Dec-11-23Upgrade Citigroup Sell → Neutral $85 → $120
Nov-10-23Downgrade Canaccord Genuity Buy → Hold $210 → $120
Feb-28-24 05:52AM
Feb-27-24 03:40AM
03:09AM
Feb-26-24 06:29PM
11:00AM
06:50AM Loading…
Feb-24-24 06:50AM
Feb-23-24 07:59AM
Feb-21-24 07:42PM
09:00AM
Feb-20-24 10:25AM
Feb-14-24 07:00PM
09:40AM
Feb-09-24 11:19AM
07:52AM
07:39AM
05:45AM Loading…
05:45AM
01:32AM
Feb-08-24 06:30PM
05:24PM
04:34PM
04:24PM
04:05PM
09:14AM
Feb-05-24 09:16AM
Feb-01-24 09:10PM
Jan-30-24 07:31AM
Jan-29-24 07:49PM
Jan-28-24 09:25AM
Jan-23-24 08:45PM
Jan-19-24 08:25AM
07:52AM Loading…
Jan-18-24 07:52AM
05:04AM
Jan-17-24 12:04PM
Jan-16-24 10:11AM
Jan-15-24 07:00AM
Jan-12-24 09:45AM
Jan-11-24 09:45AM
Jan-09-24 05:28PM
02:02PM
09:00AM
07:05AM
05:38AM
03:34AM
Jan-08-24 12:45PM
Jan-05-24 09:15AM
Jan-04-24 08:17PM
04:05PM
09:15AM
Dec-28-23 01:02PM
Dec-27-23 10:45AM
Dec-22-23 03:00PM
Dec-21-23 09:35AM
Dec-19-23 05:28PM
04:42PM
04:05PM
01:26PM
11:11AM
11:02AM
09:45AM
05:30AM
05:30AM
05:18AM
12:00AM
Dec-18-23 04:17PM
04:07PM
03:37PM
01:55PM
12:46PM
12:11PM
10:58AM
09:45AM
09:42AM
09:25AM
08:57AM
07:20AM
06:38AM
04:48AM
02:48AM
02:00AM
01:47AM
01:30AM
01:24AM
Dec-17-23 08:16PM
08:16PM
07:42PM
06:17PM
03:38PM
02:50PM
02:45PM
02:37PM
Dec-16-23 02:32PM
Dec-15-23 07:07PM
07:01PM
09:39AM
Dec-13-23 05:02AM
Dec-12-23 09:47PM
12:45PM
10:34AM
10:22AM
09:52AM
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thaysen JacobChief Executive OfficerFeb 22Buy135.297,330991,67214,861Feb 26 08:57 AM
Hoyt Aimee LSVP, Chief People OfficerNov 07Sale112.8431535,5458,314Nov 09 04:22 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerAug 22Sale167.0450083,52045,524Aug 24 04:19 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerJul 24Sale190.0850095,04046,022Jul 26 06:14 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerJun 22Sale200.00500100,00046,522Jun 26 05:23 PM
EPSTEIN ROBERT SDirectorMay 25Option Exercise71.097,600540,28414,764May 25 04:34 PM